After the Sequence

At the Loom, Carl Zimmer bemoans what he dubs the "Yet-Another-Genome Syndrome." Sequencing a genome, he writes, used to be different — it took forever to do and was a big deal when it came out — but with next-generation sequencing, it takes comparatively no time at all, yet they still generate tons of press releases and news articles. It's what comes after the sequencing, Zimmer says, that is interesting.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.